Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways

Free Radical Biology and Medicine

Volumn 46, Issue 9, 2009, Pages 1267-1274

  Balantinou, Eirini ^a   Trougakos, Ioannis P ^a   Chondrogianni, Niki ^a   Margaritis, Lukas H ^b   Gonos, Efstathios S ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Clusterin; Free radicals; Heat shock factor 1; Lysosome; Proteasome

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CLUSTERIN; CYCLOHEXIMIDE; EPOXOMICIN; FREE RADICAL; HEAT SHOCK TRANSCRIPTION FACTOR 1; PROTEASOME;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IONIZING RADIATION; LYSOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; ULTRAVIOLET RADIATION;

ANTIBODIES, BLOCKING; CELL LINE, TUMOR; CLUSTERIN; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; HYDROLYSIS; LEUPEPTINS; LYSOSOMES; MALE; OLIGOPEPTIDES; OSTEOSARCOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UBIQUITIN;

EID: 63649144419     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.01.025     Document Type: Article

References (36)

1. Trougakos I.P., and Gonos E.S. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radic. Res. 40 (2006) 1324-1334
2. Jones S.E., and Jomary C. Clusterin. Int. J. Biochem. Cell Biol. 34 (2002) 427-431
3. Trougakos I.P., and Gonos E.S. Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol. 34 (2002) 1430-1448
4. Michel D., Chatelain G., North S., and Brun G. Stress-induced transcription of the clusterin/ApoJ gene. Biochem. J. 328 (1997) 45-50
5. Loison F., Debure L., Nizard P., le Goff P., Michel D., and le Drean Y. Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes. Biochem. J. 395 (2006) 223-231
6. Wilson M.R., and Easterbrook-Smith S.B. Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25 (2000) 95-98
7. Ammar H., and Closset J.L. Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 283 (2008) 12851-12861
8. Rosenberg M.E., and Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol. 27 (1995) 633-645
9. Trougakos I.P., So A., Jansen B., Gleave M.E., and Gonos E.S. Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability and cell sensitization to genotoxic and oxidative stress. Cancer Res. 64 (2004) 1834-1842
10. Trougakos I.P., Lourda M., Agiostratidou G., Kletsas D., and Gonos E.S. Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic. Biol. Med. 38 (2005) 436-449
11. Trougakos I.P., Lourda M., Antonelou M.H., Kletsas D., Gorgoulis V.G., Papassideri I.S., Zou Y., Margaritis L.H., Boothman D.A., and Gonos E.S. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin. Cancer Res. 15 (2009) 48-59
12. Chondrogianni N., and Gonos E.S. Proteasome dysfunction in mammalian aging: steps and factors involved. Exp. Gerontol. 40 (2005) 931-938
13. Friguet B., Bulteau A.L., Chondrogianni N., Conconi M., and Petropoulos I. Protein degradation by the proteasome and its implications in aging. Ann. N. Y. Acad. Sci. 908 (2000) 143-154
14. Ciechanover A. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Hematol. Am. Soc. Hematol. Educ. Program 1-12 (2006) 505-506
15. Chondrogianni N., Fragoulis E.G., and Gonos E.S. Protein degradation during aging: the lysosome-, the calpain-and the proteasome-dependent cellular proteolytic systems. Biogerontology 3 (2002) 121-123
16. Grune T., Reinheckel T., and Davies K.J.A. Degradation of oxidized proteins in mammalian cells. FASEB J. 11 (1997) 526-534
17. Sitte N., Merker K., Von Zglinicki T., Grune T., and Davies K.J.A. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts. Part I. Effects of proliferative senescence. FASEB J. 14 (2000) 2495-2502
18. Cuervo A.M., and Dice J.F. When lysosomes get old. Exp. Gerontol. 35 (2000) 119-131
19. Yeung S.J., Chen S.H., and Chan L. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B. Biochemistry 35 (1996) 13843-13848
20. Petropoulou C., Trougakos I.P., Kolettas E., Toussaint O., and Gonos E.S. Clusterin/apolipoprotein J is a novel biomarker of cellular senescence, that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett. 509 (2001) 287-297
21. Grossin L., Etienne S., Gaborit N., Pinzano A., Cournil-Henrionnet C., Gerard C., Payan E., Netter P., Terlain B., and Gillet P. Induction of heat shock protein 70 (Hsp70) by proteasome inhibitor MG 132 protects articular chondrocytes from cellular death in vitro and in vivo. Biorheology 41 (2004) 521-534
22. Criswell T., Beman M., Araki S., Leskov K., Cataldo E., Mayo L.D., and Boothman D.A. Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor. J. Biol. Chem. 280 (2005) 14212-14221
23. Morales C.R., Igdoura S.A., Wosu U.A., Boman J., and Argraves W.S. Low density lipoprotein receptor-related protein-2 expression in efferent duct and epididymal epithelia: evidence in rats for its in vivo role in endocytosis of apolipoprotein J/clusterin. Biol. Reprod. 55 (1996) 676-683
24. Bartl M.M., Luckenbach T., Bergner O., Ullrich O., and Koch-Brandt C. Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp. Cell Res. 271 (2001) 130-141
25. Gutacker C., Klock G., Diel P., and Koch-Brandt C. Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells. Biochem. J. 339 (1999) 759-766
26. Boothman D.A., Meyers M., Fukunaga N., and Lee S.W. Isolation of X-ray-inducible transcripts from radioresistant human melanoma cells. Proc. Natl. Acad. Sci. USA 90 (1993) 7200-7204
27. Miyake H., Nelson C., Rennie P.S., and Gleave M.E. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models. Cancer Res. 60 (2000) 2547-2554
28. Kawazoe Y., Nakai A., Tanabe M., and Nagata K. Proteasome inhibition leads to the activation of all members of the heat-shock-factor family. Eur. J. Biochem. 255 (1998) 356-362
29. Bayon Y., Ortiz M.A., Lopez-Hernandez F.J., Howe P.H., and Piedrafita F.J. The retinoid antagonist MX781 induces clusterin expression in prostate cancer cells via heat shock factor-1 and activator protein-1 transcription factors. Cancer Res. 64 (2004) 5905-5912
30. Carreras I., Garrett-Young R., Ullman M.D., Eisenhauer P.B., Fine R.E., Wells J.M., and Conn K.J. Upregulation of clusterin/apolipoprotein J in lactacystin-treated SH-SY5Y. J. Neurosci. Res. 79 (2005) 495-502
31. Nizard P., Tetley S., Le Dréan Y., Watrin T., Le Goff P., Wilson M.R., and Michel D. Stress-induced retrotranslocation of clusterin/ApoJ into the cytosol. Traffic 8 (2007) 554-565
32. Debure L., Vayssiere J.L., Rincheval V., Loison F., Le Drean Y., and Michel D. Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration. J. Cell Sci. 116 (2003) 3109-3121
33. Bell R.D., Sagare A.P., Friedman A.E., Bedi G.S., Holtzman D.M., Deane R., and Zlokovic B.V. Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab. 27 (2007) 909-918
34. Eskelinen E.L., and Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim. Biophys. Acta. (2008)
35. Bandyopadhyay U., and Cuervo A.M. Entering the lysosome through a transient gate by chaperone-mediated autophagy. Autophagy 4 (2008) 1101-1103
36. Chi K.N., Eisenhauer E., Fazli L., Jones E.C., Goldenberg S.L., Powers J., Tu D., and Gleave M.E. A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2′-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer. J. Natl. Cancer Inst. 97 (2005) 1287-1296